Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Operating activities
Net loss	$ (14,264)	$ (17,352)
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest	(180)	(536)
Income (Loss) from Continuing Operations, Including Portion Attributable to Noncontrolling Interest	(14,084)	(16,816)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities - continuing operations:
Depreciation and amortization	10,753	11,144
Deferred rent	(58)	45
Deferred ground rents	2,041	2,041
Interest amortization and interest accrued on related party notes	3,234	3,006
Below-market lease amortization	(232)	(250)
Equity in net (earnings) loss of unconsolidated joint ventures	(497)	1,147
Bad debt expense	156	2
Changes in operating assets and liabilities:
Restricted cash for operating activities	(805)	543
Rents and other receivables	(360)	78
Other assets	571	7
Accounts payable and other liabilities	120	(1,021)
Net Cash Provided by (Used in) Operating Activities, Continuing Operations	839	(74)
Cash Provided by (Used in) Operating Activities, Discontinued Operations	(135)	120
Net cash provided by operating activities	704	46
Investing activities
Additions to and improvement of real estate	(4,777)	(6,416)
Distributions from unconsolidated joint ventures	875	207
Contributions to unconsolidated joint ventures	(10)	(182)
Proceeds from Sale of Property Held-for-sale	8,552	0
Payment of leasing commissions	(1,213)	(1,059)
Interim financing provided to unconsolidated joint ventures	0	(175)
Repayment of interim financing by unconsolidated joint venture	0	358
Change in restricted cash used for capital expenditures	(108)	154
Net cash provided by (used in) investing activities	3,319	(7,113)
Financing activities
Repayment of mortgage notes payable	(6,295)	(507)
Security deposits	59	(7)
Financing Costs	0	(5)
Senior Common Stock dividends	(874)	(874)
Net cash used in financing activities	(7,110)	(1,393)
Decrease in cash and cash equivalents	(3,087)	(8,460)
Cash and cash equivalents at beginning of period	6,904	15,364
Cash and cash equivalents at end of period	3,817	6,904
Supplemental cash flow information
Interest paid	17,386	17,621
Supplemental disclosure of non-cash investing and financing activities
Accrued dividends and distributions	3,147	3,147
Change in accrued capital expenditures	$ 164	$ (1,170)